Article
Genetic variation that predicts platinum sensitivity reveals the role of miR-193b* in chemotherapeutic susceptibility.
Molecular cancer therapeutics - 1 Sept 2012
Ziliak Dana, Gamazon Eric R, Lacroix Bonnie, Kyung Im Hae, Wen Yujia, Huang Rong Stephanie
Abstract excerpt
Platinum agents are the backbone of cancer chemotherapy. Recently, we identified and replicated the role of a single nucleotide polymorphism (SNP, rs1649942) in predicting platinum sensitivity both in vitro and in vivo. Using the CEU samples from the International HapMap Project, we found the same SNP to be a master regulator of multiple gene expression phenotypes, prompting us to investigate whether...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
